U.S. Food and Drug Administration
FDA Guidance Recap Podcast
The Guidance Recap Podcast provides highlights for FDA guidance documents straight from the authors. Through conversations with FDA staff, this podcast is intended help communicate salient key points and background information about a subset of cross-cutting guidance documents on topics that seek to modernize and accelerate drug development.
Author
U.S. Food and Drug Administration
Category
Podcast website
Latest episode
Jul 7, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Guidance Recap Podcast | Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations 07.07.2026 8:51
Guidance Recap Podcast | Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations
Guidance Recap Podcast | Master Protocols for Drug and Biological Product Development 22.06.2026 14:54
Guidance Recap Podcast | Master Protocols for Drug and Biological Product Development
Guidance Recap Podcast | Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products 25.03.2026 13:01
Guidance Recap Podcast | Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products
Guidance Recap Podcast | Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments 22.10.2025 8:57
Guidance Recap Podcast: Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments
Guidance Recap Podcast | Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development 16.10.2024 12:09
Guidance Recap Podcast | Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development
Guidance Recap Podcast | Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies 18.09.2024 18:04
Guidance Recap Podcast | Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies
Guidance Recap Podcast | Digital Health Technologies for Remote Data Acquisition in Clinical Investigations 24.07.2024 24:04
Guidance Recap Podcast | Digital Health Technologies for Remote Data Acquisition in Clinical Investigations
Guidance Recap Podcast | Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics 15.07.2024 14:56
Guidance Recap Podcast | Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics
Guidance Recap Podcast | E19 A Selective Approach to Safety Data Collection in Specific Late-Stage Pre-approval or Post-approval Clinical Trials 22.04.2024 12:15
Guidance Recap Podcast | E19 A Selective Approach to Safety Data Collection in Specific Late-Stage Pre-approval or Post-approval Clinical Trials
Guidance Recap Podcast | Pharmacokinetics Study Design Considerations in Patients with Impaired Renal Function — Study Design, Data Analysis, and Impact on Dosing 16.04.2024 12:04
Guidance Recap Podcast | Pharmacokinetics Study Design Considerations in Patients with Impaired Renal Function — Study Design, Data Analysis, and Impact on Dosing
Guidance Recap Podcast | Clinical Pharmacology Considerations for Antibody-Drug Conjugates 26.03.2024 12:02
Guidance Recap Podcast | Clinical Pharmacology Considerations for Antibody-Drug Conjugates
Guidance Recap Podcast | Drug-Drug Interaction Assessment for Therapeutic Proteins 11.12.2023 13:29
Guidance Recap Podcast | Drug-Drug Interaction Assessment for Therapeutic Proteins
Guidance Recap Podcast | Translation of Good Laboratory Practice Study Reports: Questions and Answers 21.11.2023 13:39
Highlights for FDA guidance documents straight from the authors
Guidance Recap Podcast | Benefit-Risk Assessment for New Drug and Biologic Products 19.10.2023 12:55
Guidance Recap Podcast: Benefit-Risk Assessment for New Drug and Biologic Products
Guidance Recap Podcast | Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products 25.05.2023 7:34
Guidance Recap Podcast | Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products
Guidance Recap Podcast | Use of Whole Slide Imaging in Nonclinical Toxicology Studies: Questions and Answers 24.05.2023 11:22
Guidance Recap Podcast | Use of Whole Slide Imaging in Nonclinical Toxicology Studies: Questions and Answers
Guidance Recap Podcast | Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents: Study Design, Data Analysis, and Clinical Implications 15.05.2023 12:45
Guidance Recap Podcast | Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents: Study Design, Data Analysis, and Clinical Implications
Guidance Recap Podcast | Multiple Endpoints in Clinical Trials 20.10.2022 11:49
Guidance Recap Podcast | Multiple Endpoints in Clinical Trials
Guidance Recap Podcast | Ethical Considerations for Clinical Investigations of Medical Products Involving Children 23.09.2022 14:52
Thoughts on newly published draft guidance titled, “Ethical Considerations for Clinical Investigations of Medical Products Involving Children.”
Guidance Recap Podcast | General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products 26.07.2022 8:41
Guidance Recap Podcast: General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products
Guidance Recap Podcast | Bioavailability Studies Submitted in NDAs or INDs – General Considerations 14.04.2022 8:02
Guidance Recap Podcast: Bioavailability Studies Submitted in NDAs or INDs – General Considerations
Guidance Recap Podcast | Population Pharmacokinetics 04.02.2022 6:24
Guidance Recap Podcast: Population Pharmacokinetics
Guidance Recap Podcast | Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers 27.12.2021 12:20
Recap Podcast: Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers
Guidance Recap Podcast | Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biologics 21.05.2021 6:59
Dr. Dan Rubin, statistician, Division of Biometrics IV in CDER’s Office of Biostatistics sharing some thoughts draft guidance Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biologics
Guidance Recap Podcast | Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products Podcast 15.12.2020 11:33
The Guidance Recap Podcast provides highlights for FDA guidance documents straight from the authors.
Similar podcasts
Listen to the FDA Guidance Recap Podcast podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
